EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review

Fernanda Priscila Barbosa Ribeiro iD, Micaelle Oliveira de Luna Freire iD, Daniella de Oliveira Coutinho iD, Marry Aneyts de Santana Cirilo iD, José Luiz de Brito Alves iD

Probiotics and Antimicrobial Proteins · 2025-08 · 17 (4) · 1797-1819

DOI: 10.1007/s12602-024-10427-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 13.12.2024. Verfasst von Fernanda Priscila Barbosa Ribeiro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Health Sciences Center, Federal University of Paraíba, Campus I - Jd, Cidade Universitária, João Pessoa, 58051-900, Brazil. Hauptthemen laut MEDLINE: Probiotics, Dysbiosis, Renal Insufficiency, Chronic, Gastrointestinal Microbiome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 135 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a multifactorial disease affecting more than 13.4% of the world's population and is a growing public health problem. It is silent in its early stages and leads to irreversible kidney damage as the disease progresses. A key factor in this progression is the bidirectional relationship between CKD and gut dysbiosis, which creates an imbalance that promotes the accumulation of uremic toxins (UTs), contributing to renal fibrosis, endothelial dysfunction, and decreased glomerular filtration rate. In addition, CKD itself exacerbates gut dysbiosis by altering the composition of the gut microbiota (GM) and promoting the growth of pathogenic microorganisms. Therefore, it is crucial to explore new therapeutic strategies, and the use of probiotics and synbiotics has shown promise in modulating the GM. Numerous preclinical studies have shown that the use of probiotics in CKD has a beneficial effect on the kidney by reducing UTs, apoptosis, inflammation, and oxidative stress. Probiotic treatment has also been associated with restoration of intestinal integrity, modulation of microbial composition and diversity, and increased production of short-chain fatty acids (SCFAs). These positive results have also been observed in patients at different stages of CKD, where the use of probiotics and/or synbiotics was able to improve creatinine levels and uremic parameters and alleviate abdominal discomfort, in addition to modulating GM and reducing serum endotoxin levels. Although recent studies have explored the benefits of probiotics in the treatment of CKD, further research is needed to determine their long-term efficacy and clinical relevance. This review focuses on the factors driving gut dysbiosis in CKD, its role in disease progression, and the potential of probiotics as a therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsDysbiosisRenal Insufficiency, ChronicGastrointestinal MicrobiomeHumansAnimalsSynbiotics

Stichwörter der Autor:innen

Chronic kidney diseaseGut dysbiosisGut microbiotaProbiotic

Autor:innen und Institutionen

  • Department of Nutrition, Health Sciences Center, Federal University of Paraíba, Campus I - Jd, Cidade Universitária, João Pessoa, 58051-900, Brazil.
  • Department of Physiology and Pharmacology, Federal University of Pernambuco, 50.670-901, Recife, Brazil.
  • Department of Nutrition, Health Sciences Center, Federal University of Paraíba, Campus I - Jd, Cidade Universitária, João Pessoa, 58051-900, Brazil. jose.luiz@academico.ufpb.br.

ORCID-Profile: Fernanda Priscila Barbosa Ribeiro, Micaelle Oliveira de Luna Freire, Daniella de Oliveira Coutinho, Marry Aneyts de Santana Cirilo, José Luiz de Brito Alves

Zitieren

APA

Ribeiro, F. P. B., de Luna Freire, M. O., de Oliveira Coutinho, D., de Santana Cirilo, M. A., & de Brito Alves, J. L. (2025). Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review. Probiotics and Antimicrobial Proteins, 17(4), 1797-1819. https://doi.org/10.1007/s12602-024-10427-9

Vancouver

Ribeiro FPB, de Luna Freire MO, de Oliveira Coutinho D, de Santana Cirilo MA, de Brito Alves JL. Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review. Probiotics and Antimicrobial Proteins. 2025;17(4):1797-1819. doi:10.1007/s12602-024-10427-9

BibTeX
@article{Ribeiro2025,
  author = {Ribeiro, Fernanda Priscila Barbosa and de Luna Freire, Micaelle Oliveira and de Oliveira Coutinho, Daniella and de Santana Cirilo, Marry Aneyts and de Brito Alves, José Luiz},
  title = {Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {1797--1819},
  doi = {10.1007/s12602-024-10427-9}
}
Kostenlos starten →